Insider Transactions in Q1 2021 at National Healthcare Corp (NHC)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2021
|
Ernest G Burgess Iii Director |
SELL
Bona fide gift
|
Direct |
1,300
-0.73%
|
-
|
|
Mar 18
2021
|
Jeffrey Russell Smith SVP & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
43,811
-87.8%
|
$3,461,069
$79.21 P/Share
|
|
Mar 18
2021
|
Jeffrey Russell Smith SVP & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
46,630
+48.31%
|
$3,357,360
$72.74 P/Share
|
|
Mar 15
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
13,109
-64.62%
|
$1,022,502
$78.99 P/Share
|
|
Mar 15
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+44.1%
|
$960,000
$60.73 P/Share
|
|
Mar 15
2021
|
Emil E Hassan Director |
SELL
Open market or private sale
|
Direct |
1,913
-2.92%
|
$151,127
$79.0 P/Share
|
|
Mar 02
2021
|
James Paul Abernathy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,020
+6.91%
|
$123,220
$61.9 P/Share
|
|
Mar 02
2021
|
Robert G Adams Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,750
+0.64%
|
$198,000
$72.94 P/Share
|
|
Feb 24
2021
|
Vicki L Dodson Sr.VP Patient Srvcs |
BUY
Grant, award, or other acquisition
|
Direct |
421
+20.73%
|
-
|
|
Feb 24
2021
|
Josh A Mc Creary Senior VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
633
+37.52%
|
-
|
|
Feb 24
2021
|
Brian F Kidd SVP, Controller, PAO |
BUY
Grant, award, or other acquisition
|
Direct |
626
+3.52%
|
-
|
|
Feb 24
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
510
+10.64%
|
-
|
|
Feb 24
2021
|
Stephen Fowler Flatt CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,650
+3.15%
|
-
|
|
Feb 24
2021
|
Jeffrey Russell Smith SVP & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
739
+18.45%
|
-
|
|
Feb 24
2021
|
Ben Anderson Sr Flatt Senior VP & CIO |
BUY
Grant, award, or other acquisition
|
Direct |
742
+13.77%
|
-
|
|
Feb 24
2021
|
Robert Michael Ussery President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
1,565
+1.05%
|
-
|
|
Jan 06
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
6,905
-64.65%
|
$504,065
$73.97 P/Share
|
|
Jan 06
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+42.83%
|
$480,000
$60.73 P/Share
|
|
Jan 01
2021
|
Stephen Fowler Flatt CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
414
-0.84%
|
$27,324
$66.41 P/Share
|
|
Jan 01
2021
|
Jeffrey Russell Smith SVP & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
174
-6.44%
|
$11,484
$66.41 P/Share
|
|
Jan 01
2021
|
Josh A Mc Creary Senior VP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-9.85%
|
$3,036
$66.41 P/Share
|
|
Jan 01
2021
|
Leroy E. Mc Intosh Jr. SVP, Anc Srvcs & Srvc Strategy |
SELL
Payment of exercise price or tax liability
|
Direct |
122
-4.35%
|
$8,052
$66.41 P/Share
|
|
Jan 01
2021
|
Vicki L Dodson Sr.VP Patient Srvcs |
SELL
Payment of exercise price or tax liability
|
Direct |
26
-2.32%
|
$1,716
$66.41 P/Share
|